Purdue's NCAA Tournament history vs. double-digit seeds has been well documented, but there's another stat that stands out, too. After losing to Houston 62-60 on Friday night in Indianapolis ...

Indian pharma stocks, including Sun Pharmaceutical Industries, Gland Pharma, Lupin and others traded sharply lower on Wednesday after the US President Donald Trump said he will soon announce a ...

HAIKOU, China, April 4, 2025 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-for-10 reverse stock split ...

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut ...

Opioid settlements with companies like Purdue Pharma, Walmart, and Johnson & Johnson have led to headline-grabbing multibillion-dollar payouts, but most of the windfall is flowing to state and ...

The stock movement reflects investor optimism about the potential impact of TONIX ONE on Tonix Pharmaceuticals’ business development and the value it could create across its product portfolio ...

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...

Purdue Pharma has filed a new bankruptcy plan that details how the funds will be allocated and the proportion paid by its owners, nearly two months after agreeing to a $7.4bn opioid settlement.

Share price of JAZZ Pharmaceuticals JAZZ hit $102.82 on Tuesday ... weaknesses to gain a better understanding of how to play the stock amid this price decline. Jazz derives a substantial portion ...

Shares of Biocon will be in focus in Friday after the pharma major said its subsidiary ... Bevacizumab for intravenous use. Biocon stock ended 5.33% lower at Rs 305.20 on Wednesday against the ...

Last month, Purdue Pharma filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, after the ...